GMVAX
Price
$16.05
Change
-$0.39 (-2.37%)
Updated
Feb 21 closing price
Net Assets
143.92M
VEXAX
Price
$144.57
Change
-$4.57 (-3.06%)
Updated
Feb 21 closing price
Net Assets
116.7B
Ad is loading...

GMVAX vs VEXAX

Header iconGMVAX vs VEXAX Comparison
Open Charts GMVAX vs VEXAXBanner chart's image
Goldman Sachs Small/Mid Cap Value A
Price$16.05
Change-$0.39 (-2.37%)
VolumeN/A
Net Assets143.92M
Vanguard Extended Market Index Admiral
Price$144.57
Change-$4.57 (-3.06%)
VolumeN/A
Net Assets116.7B
GMVAX vs VEXAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMVAX vs. VEXAX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVAX is a Hold and VEXAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEXAX has more cash in the bank: 117B vs. GMVAX (144M). VEXAX pays higher dividends than GMVAX: VEXAX (1.20) vs GMVAX (0.57). GMVAX was incepted earlier than VEXAX: GMVAX (11 years) vs VEXAX (24 years). GMVAX is a more actively managed with annual turnover of: 56.00 vs. VEXAX (11.00). GMVAX has a lower initial minimum investment than VEXAX: GMVAX (1000) vs VEXAX (3000). VEXAX annual gain was more profitable for investors over the last year : 14.31 vs. GMVAX (5.44). VEXAX return over 5 years is better than : 47.41 vs. GMVAX (23.96).
GMVAXVEXAXGMVAX / VEXAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD-1.8350.340-540%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets144M117B0%
Annual Yield % from dividends0.571.2047%
Returns for 1 year5.4414.3138%
Returns for 3 years0.2221.161%
Returns for 5 years23.9647.4151%
Returns for 10 years49.19115.9642%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO12.280.58
+4.96%
Alvotech
WEST6.350.10
+1.60%
Westrock Coffee Company
LPTX0.48N/A
-0.52%
Leap Therapeutics
LPLA372.13-7.33
-1.93%
LPL Financial Holdings
OPRX5.78-0.41
-6.62%
OptimizeRx Corp